Back to Search
Start Over
AML-437 Real-World Effectiveness of Enasidenib (ENA) in Older Patients With Relapsed/Refractory (R/R) Isocitrate Dehydrogenase-2 (IDH2)-Mutated Acute Myeloid Leukemia (AML)
- Source :
- Clinical Lymphoma Myeloma and Leukemia. 22:S250-S251
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 21522650
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Clinical Lymphoma Myeloma and Leukemia
- Accession number :
- edsair.doi...........b6ceef72b490091b7251cf679b06c744
- Full Text :
- https://doi.org/10.1016/s2152-2650(22)01295-2